Abstract:OBJECTIVE:To investigate the effects of various concentrations of taurine on streptozotocin (STZ)-induced diabetic cataracts in rats by biochemistry, radioimmunology and capillary zone electrophoresis (CZE).METHODS:One hundred Sprague-Dowley (SD) male rats, weight 180 approximately 200 g, were randomly divided into 5 groups: normal control, STZ plus saline, STZ plus 2% taurine, STZ plus 4% taurine and STZ plus 8% taurine groups. After being fasted for 12 hours, the rats of the STZ group (with or without taurine) were prepared by STZ intraperitoneal injection (55 mg/kg b.w.). Taurine-treated groups received 2%, 4% and 8% taurine injections once daily for 12 weeks (5 ml/kg b.w.). STZ group without taurine received a saline injection once daily for 12 weeks (5 ml/kg b.w.). During the experiment period, blood sugar was measured by ONE TOUCH II. At the end of experiment, several biochemical parameters were measured by Beckman CX-7, insulin was measured by (125)I-insulin radioimmunological detecting kit and the level of taurine in the aqueous humor and the lens was measured by Beckman 5500 capillary zone electrophoresis (CZE) model.RESULTS:Three weeks after the administration of STZ, the lenses showed vesicle and light opacity in the STZ group. Taurine suppressed the occurrence of early stage cataract obviously. Four to 12 weeks after the administration of STZ, the lens opacity in the 4% and 8% taurine treatment groups was markedly delayed as compared with that of the STZ group. The level of blood glucose in the 4% and 8% taurine groups was decreased evidently compared to that of the STZ group on 4 days, 4 weeks, and 8 weeks (the 4% taurine group). No difference could be detected between the STZ group and taurine treatment groups in 12 weeks. In the 4% and 8% taurine groups, the level of triglycerides decreased markedly compared to that of the STZ group and was near that of the control group. There were no differences of other biochemical parameters among all groups. In the 8% taurine group, the level of taurine in the aqueous humor and lens was increased obviously compared to that of the STZ group (P = 0.036 or P = 0.000, respectively).CONCLUSION:The intervening effect of taurine on STZ-induced diabetic cataract is dose-dependent. This effect is not only related to decreases in the levels of blood sugar and triglycerides, but is also related to an increase in the taurine level in the aqueous humor and lens of diabetic rats, which enables the lens to escape from oxidant injury.

Effect of taurine on L-arginine/NO pathway in erythrocytes of rats of hypertension with insulin resistance induced by fructose

Dysfunction of myocardial and vascular taurine transport in L-N ω-nitro-arginine-induced hypertensive rats

Taurine Supplementation Alleviates Blood Pressure via Gut–Brain Communication in Spontaneously Hypertensive Rats

Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats

Dose-dependent effects of taurine against testicular damage in a streptozotocin-induced type 1 diabetes mellitus rat model

Taurine Attenuates Oxidative Stress and Alleviates Cardiac Failure in Type I Diabetic Rats

Taurine attenuates the vascular calcification and L-arginine/NO pathway impairement induced by vitamin D3 and nicotine in rat

Alleviation of taurine on liver injury of type 2 diabetic rats by improving antioxidant and anti-inflammatory capacity

Effect of taurine on the differentiation of 3T3-L1 preadipocytes

Microglial activation and toll-like receptor 4-Dependent regulation of angiotensin II type I receptor-mu-opioid receptor 1 heterodimerization and hypertension in fructose-fed rats

Superoxide dismustase mimetic tempol decreases blood pressure by increasing renal medullary blood flow in hyperinsulinemic-hypertensive rats

Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction

Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: a randomized, clinical trial

HYPERGLYCEMIA INHIBITED TAURINE TRANSPORT AND TAURINE TRANSPORTER GENE EXPRESSION IN CULTURED RAT CARDIOMYOCYTES

Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats

Dysfunction of Myocardial and Vascular Taurine Transport in Spontaneously Hypertensive Rats.

Inhibition of taurine transport by high concentration of glucose in cultured rat cardiomyocytes

The Renal L-arginine/nitric Oxide Pathway and Erythrocyte L-arginine Transport in Spontaneously Hypertensive Rats

Study on the Intervening Mechanism of Taurine on Streptozotocin-Induced Diabetic Cataracts

Antihypertensive effect of total flavones extracted from seed residues of Hippophae rhamnoides L. in sucrose-fed rats

A systematic review of preclinical studies on the taurine role during diabetic nephropathy: focused on anti-oxidative, anti-inflammation, and anti-apoptotic effects